Delivery Order SPE2DR25D2106-SPE2DR26F1FQB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,206.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed price delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a non-competitive award under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,905.14 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded September 26, 2025, represents a non-competitive, non-set-aside procurement with a completion deadline of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $23,115.58 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack), a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries...
- The Defense Logistics Agency awarded a delivery order valued at $28,410.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, with an ultimate completion date of August 21, 2025, was awarded on August 20, 2025, with no set-aside designation. The contract represents a competitive award under AmerisourceBergen's larger federal contracting relationship with DLA and reflects...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a $39,167.67 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a $16,873.06 delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml autoinjector medication, with a completion date of October 29, 2025. This competitive award uses firm fixed pricing and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of TALTZ 80 mg/ml autoinjectors, valued at $42,488.12. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitively awarded contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This award represents a...
- The Defense Logistics Agency awarded a $15,731.15 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1FQBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,286.99 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a biologic medication used primarily to treat inflammatory conditions such as psoriasis and psoriatic arthritis. This competitively awarded, firm fixed-price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The DLA leverages this prime indefinite delivery vehicle to efficiently fulfill pharmaceutical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 11/7/25 |